Anesthesia spearheading perioperative safety efforts in a patient with inclusion body myositis: A case report
- Author:
Maria Teresita B. Aspi
1
;
Anne Kay Colleen V. Arancon
2
Author Information
- Publication Type:Case Reports
- Keywords: Case report
- MeSH: Patient Safety; Myositis, Inclusion Body; Malignant Hyperthermia
- From: Acta Medica Philippina 2024;58(9):84-87
- CountryPhilippines
- Language:English
- Abstract: Anesthesiologists have been at the forefront of initiatives addressing perioperative patient safety. As anesthesia has no direct therapeutic benefit, its risk must be minimized. At times the surgery is simple but the patient’s condition complicates anesthetic management, increasing the risk for complications. This report describes the anesthetic management of an adult patient diagnosed with inclusion body myositis (IBM), a rare inflammatory degenerative myopathy, who initially presented with decreased motor function in both lower and upper extremities causing him to be bedbound for two years. Due to the progression of his disease, he eventually developed dysphagia, hence he was scheduled for esophagoscopy, cricopharyngeal Botox injection, and percutaneous endoscopic gastrostomy. As patients with IBM are at risk for exaggerated sensitivity to neuromuscular blockers and respiratory compromise, anesthesia was at the helm of a multidisciplinary team approach. The perioperative management centered on preoperative optimization, prevention of aspiration, avoidance of anesthetics that may trigger malignant hyperthermia, and prevention of postoperative pulmonary complication. The hospital course was uncomplicated and the patient was discharged well after one day. This report emphasizes how improvements in resources, technology, and healthcare delivery, especially in anesthesia, help prevent perioperative adverse events.
- Full text:20240613125443545558830-Article Text-158473-1-10-20240523.pdf
